GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Sotalol

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

High-risk QT-active drug: the historical source is not a complete initiation/reinitiation, QT, electrolyte or monitored-titration protocol. Do not apply its nonspecific HD supplement automatically across indications/products.

Check source scope before reading a dose

Betapace - labeled renal guidance

Product / population
Sotalol hydrochloride (Betapace), oral tablet
Renal method
Creatinine clearance (CrCl), mL/min
Source revision
DailyMed SPL version 2, posted Dec 20, 2024
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Betapace - product and source limitations

Use the full initiation or reinitiation protocol. Hemodialysis removes some drug but the label supplies no dialysis regimen.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Betapace - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Sotalol hydrochloride (Betapace), oral tablet

Renal method: Creatinine clearance (CrCl), mL/min
Source date: DailyMed SPL version 2, posted Dec 20, 2024
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 2.5 Dosage for Patients with Renal Impairment / 8.6 Renal Impairment

In renal impairment select the interval by CrCl, monitor heart rate and QTc, and allow at least five doses at the appropriate interval before increasing the dose. Use the full initiation or reinitiation protocol. Hemodialysis removes some drug but the label supplies no dialysis regimen.

RDM74-betapace-official-1 · Source locator: Renal guidance: 2.5 Dosage for Patients with Renal Impairment / 8.6 Renal Impairment

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6a7702f-36c9-45db-b640-453dc324baee
Retrieved
2026-11-07
Renal-function method
Creatinine clearance (CrCl), mL/min
Source date/version
DailyMed SPL version 2, posted Dec 20, 2024
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
9ce8755dc5591500c1fdcaa2b3e8d7d33f72dd8a97204b5e46c342e20ffa35df

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=sotalol&s1=RDM74-betapace-official&h1=28b6d80cf9617e522d879d15f34d5c1abe6da7447875f6d227005fe600613b61

Top